Antiangiogenic therapy in oncology: current status and future directions.

By G. Jayson, R. Kerbel, L. Ellis, Adrian L. Harris. The Lancet, 2016

736 citations recorded by the source corpus.

Subfields: Molecular Biology, Pulmonary and Respiratory Medicine, Reproductive Medicine

View Paper: https://www.semanticscholar.org/paper/39e4d8348db203ca6f95b1bd96fbb5efa6e54f89

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Molecular Biology

1. R. Apte
2. Daniel Chen
3. N. Ferrara
4. B. Larrivée
5. C. Viallard
6. Rakesh K. Jain
7. A. Adamis
8. Peter Carmeliet

In Pulmonary and Respiratory Medicine

1. N. Ferrara
2. B. Larrivée
3. C. Viallard

Citations in the corpus

• Tumor angiogenesis and vascular normalization: alternative therapeutic targets (2017, background): “The successes and failures of VEGF blockade are thought to be highly dependent on tumor type [100].”
• VEGF in Signaling and Disease: Beyond Discovery and Development (2019, methodology): “Indeed, a variety of preclinical studies supported this hypothesis (reviewed in Ferrara and Adamis, 2016; Jayson et al., 2016).”